Feltl & Co Downgrades Tandem Diabetes Care (TNDM) to Buy
- Wall Street falls ahead of inauguration
- IBM (IBM) Tops Q4 EPS by 13c, FY17 EPS Guidance Beats Consensus
- American Express (AXP) Misses Q4 EPS by 7c, FY17 EPS Guidance Tops Views at Mid-Poinit
- Skyworks Solutions (SWKS) Tops Q1 EPS by 3c, Offers Q2 Guidance, Announces Buyback
- Synergy Pharma (SGYP) Trulance (Plecanatide) Approved by FDA
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Feltl & Co downgraded Tandem Diabetes Care (NASDAQ: TNDM) from Strong Buy to Buy.
Shares of Tandem Diabetes Care closed at $5.35 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Roth Capital Downgrades Ideal Power (IPWR) to Neutral
- Goldman Sachs (GS) PT Raised to $256.00 at Oppenheimer Following 4Q Report
- Citi Downgrades AK Steel (AKS) to Sell
Create E-mail Alert Related CategoriesDowngrades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!